Dolby Laboratories Insiders Sell US$2.6m Of Stock, Possibly Signalling Caution
Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Rosenblatt Securities Maintains Dolby Laboratories(DLB.US) With Buy Rating, Maintains Target Price $95
Barrington Maintains Dolby Laboratories(DLB.US) With Buy Rating, Maintains Target Price $100
Research Alert: CFRA Lowers Opinion On Shares Of Dolby Laboratories, Inc. To Sell From Hold
Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $100 Price Target
